[1]Inagaki[YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1933,vol.53,p.686,696;dtsch.Ref.S.133][ChemischesZentralblatt,1933,vol.104,#II,p.2133]
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-DE406210,1924,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.14,p.1412][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.14,p.1412]
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-DE447539,1927,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.15,p.1693][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.15,p.1693]
[2]CurrentPatentAssignee:ROCHEHOLDINGAG-DE447539,1927,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.15,p.1693][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.15,p.1693]
[3]CurrentPatentAssignee:ROCHEHOLDINGAG-DE447539,1927,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.15,p.1693][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.15,p.1693]
[4]CurrentPatentAssignee:ROCHEHOLDINGAG-DE482435,1929,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.16,p.2519,2521][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.16,p.2519,2521]CurrentPatentAssignee:ROCHEHOLDINGAG-DE406210,1924,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.14,p.1412][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.14,p.1412]
[5]CurrentPatentAssignee:ROCHEHOLDINGAG-DE482435,1929,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.16,p.2519,2521][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.16,p.2519,2521]CurrentPatentAssignee:ROCHEHOLDINGAG-DE406210,1924,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.14,p.1412][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.14,p.1412]
[6]CurrentPatentAssignee:ROCHEHOLDINGAG-DE482435,1929,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.16,p.2519,2521][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.16,p.2519,2521]CurrentPatentAssignee:ROCHEHOLDINGAG-DE406210,1924,C[Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.14,p.1412][Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.14,p.1412]
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: Ornidazole-induced autoimmune hepatitis.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20111001
Title: Novel small molecule drugs inhibit tumor cell metabolism and show potent anti-tumorigenic potential.
Journal: Cancer chemotherapy and pharmacology 20110701
Title: Synthesis and antitumor effect in vitro and in vivo of substituted 1,3-dihydroindole-2-ones.
Journal: Journal of medicinal chemistry 20101014
Title: Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice.
Journal: PloS one 20100101
Title: Syntheses and antiproliferative evaluation of oxyphenisatin derivatives.
Journal: Bioorganic & medicinal chemistry letters 20070515
Title: Hepatic drug metabolism and adverse hepatic drug reactions.
Journal: Veterinary pathology 19750101
Title: Morrison BL, et al. Oxyphenisatin acetate (NSC 59687) triggers a cell starvation response leading to autophagy, mitochondrial dysfunction, and autocrine TNFα-mediated apoptosis. Cancer Med. 2013 Oct;2(5):687-700.
